JP3197600004
JP3197600004
ONO PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 515.785.000.000 | 486.871.000.000 | 5.9% |
| Cost of Revenue | 141.716.000.000 | 147.950.000.000 | 4.2% |
| Gross Profit | 374.069.000.000 | 338.921.000.000 | 10.4% |
| 281.833.000.000 | 279.173.000.000 | 1.0% | |
| Operating Income | 92.236.000.000 | 59.748.000.000 | 54.4% |
| Pretax Income | 92.654.000.000 | 59.328.000.000 | 56.2% |
| Net Income Common Stockholders | 69.767.000.000 | 50.047.000.000 | 39.4% |
| -- | -- | -- | |
| -- | -- | -- |